Atea Pharmaceuticals Inc
NASDAQ:AVIR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Atea Pharmaceuticals Inc
NASDAQ:AVIR
|
US |
|
Mav Beauty Brands Inc
TSX:MAV
|
CA |
|
Jinan Acetate Chemical Co Ltd
TWSE:4763
|
CN |
|
Hardide PLC
LSE:HDD
|
UK |
|
Global Education Ltd
NSE:GLOBAL
|
IN |
|
Vetoquinol SA
PAR:VETO
|
FR |
|
Way 2 Vat Ltd
ASX:W2V
|
IL |
|
Alimera Sciences Inc
NASDAQ:ALIM
|
US |
Wall Street
Price Targets
AVIR Price Targets Summary
Atea Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
AVIR
is 8.16 USD
with a low forecast of 6.06 USD and a high forecast of 10.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AVIR's stock price target?
Price Target
8.16
USD
According to Wall Street analysts, the average 1-year price target for
AVIR
is 8.16 USD
with a low forecast of 6.06 USD and a high forecast of 10.5 USD.